Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
Consulting agrmnt
CC transcript
Notes underwriting agrmnt
|
|
ALSERES PHARMACEUTICALS INC (ALSE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/21/2014 |
8-K
| Quarterly results |
| 08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 05/23/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 04/10/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 01/06/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 12/17/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 11/14/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 08/09/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 07/31/2013 |
8-K
| Form 8-K - Current report |
| 05/17/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 04/01/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 02/21/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 01/28/2013 |
SC 13G/A
| INGALLS & SNYDER LLC reports a 0% stake in ALSERES PHARMACEUTICALS, INC. |
| 01/28/2013 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 0% stake in ALSERES PHARMACEUTICALS, INC |
| 01/08/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 11/14/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 08/13/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
| 08/06/2012 |
8-K
| Entry into a Material Definitive Agreement |
| 07/20/2012 |
8-K
| Entry into a Material Definitive Agreement |
| 07/02/2012 |
8-K
| Form 8-K - Current report |
| 06/13/2012 |
8-K
| Entry into a Material Definitive Agreement |
| 05/11/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 05/08/2012 |
8-K
| Entry into a Material Definitive Agreement |
| 05/08/2012 |
8-K
| Other Events |
| 03/29/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 03/19/2012 |
8-K
| Form 8-K - Current report |
| 02/07/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/25/2012 |
8-K
| Form 8-K - Current report |
| 12/29/2011 |
8-K
| Form 8-K - Current report |
| 12/27/2011 |
4
| GIPSON ROBERT L (10% Owner) has filed a Form 4 on ALSERES PHARMACEUTICALS INC /DE|
Txns:
| Disposed/sold 2,331,034 shares
@ $0.0025, valued at
$5.8k
|
|
| 12/27/2011 |
4
| Gipson Thomas Livingston (10% Owner) has filed a Form 4 on ALSERES PHARMACEUTICALS INC /DE|
Txns:
| Disposed/sold 537,931 shares
@ $0.0025, valued at
$1.3k
|
|
| 12/27/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/27/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|
|